Novavax, Inc.

NVAXNASDAQHealthcare● Active

$9.18

$-0.31(-3.27%)

Market Cap$1.5B

P/E Ratio—

52W High$11.97

52W Low$6.13

Avg Volume4.6M

Open$9.57

Beta2.41

Employees Ownership Insider Trades

Novavax, Inc. (NVAX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NVAX · as of Feb 26, 2026

Latest filing snapshot

749

-203-21.32%vs prior year

Novavax, Inc. (NVAX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

749

Change (1Y)

-203

Growth % (1Y)

-21.32%

Revenue / Employee

$1.50M

Net Income / Employee

$587.9K

Market Cap

$1.5B

NVAX Employee Count

1996 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-26	2025-12-31	749	-203	-21.32%
2025-02-27	2024-12-31	952	-591	-38.30%
2024-02-28	2023-12-31	1,543	-449	-22.54%
2023-02-28	2022-12-31	1,992	+451	+29.27%
2022-03-01	2021-12-31	1,541	+750	+94.82%
2021-03-01	2020-12-31	791	+626	+379.39%
2020-03-11	2019-12-31	165	-214	-56.46%
2019-03-18	2018-12-31	379	+32	+9.22%
2018-03-14	2017-12-31	347	-8	-2.25%
2017-02-27	2016-12-31	355	-88	-19.86%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Intellia Therapeutics, Inc.

ORIC Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

59$4.8B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NVAX peer comparison

About NVAX employees

NVAX Employees · Headcount

Novavax, Inc. (NVAX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Novavax, Inc. had 749 full-time employees globally. Full-time employees only. Global consolidated headcount.

Novavax, Inc. employs 749 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.50M, reflecting the company's operational efficiency.

Novavax, Inc.'s workforce decreased by 203 (21.32%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Novavax, Inc.'s revenue per employee of $1.50M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

NVAX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Novavax, Inc. had 749 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Novavax, Inc. employee counthow many employees does Novavax, Inc. haveNVAX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26